Logotype for Westport Fuel Systems Inc

Westport Fuel Systems (WPRT) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Westport Fuel Systems Inc

Q3 2025 earnings summary

30 Mar, 2026

Executive summary

  • Q3 2025 results reflect a strategic transformation, with a focus on heavy-duty and alternative fuel systems after divesting the light-duty segment.

  • Sospira/Cespira joint venture delivered 19% year-over-year revenue growth to $19.3 million, expanding its OEM customer base and geographic reach.

  • Manufacturing for high-pressure controls is transitioning from Italy to Canada and China, with both new facilities expected online by year-end.

  • Enhanced liquidity with $33.1 million in cash and less than $4 million in debt at quarter-end.

  • Transformation initiatives led to improved gross margin and operational efficiency.

Financial highlights

  • Q3 2025 revenue was $1.6 million, down from $4.9 million in Q3 2024, reflecting the end of the transitional service agreement and light-duty divestiture.

  • Adjusted EBITDA was negative $5.9 million, compared to negative $0.8 million in Q3 2024, mainly due to lower gross profit post-divestiture.

  • Net loss from continuing operations was $10.4 million, versus $6 million in the prior year quarter, impacted by higher R&D, SG&A, and FX losses.

  • Gross margin improved to 31% in Q3 2025 from 14% in Q3 2024, driven by higher-margin engineering services.

  • Sospira/Cespira revenue reached $19.3 million, up 19% year-over-year, but gross profit remained negative at -$1.1 million.

Outlook and guidance

  • Further cost reductions are expected as the organization adjusts post-divestiture, with CapEx and SG&A planned to be reduced by 60% and 15%, respectively, in 2026.

  • Sospira/Cespira aims for continued volume growth, new OEM customers, and expansion into new geographies.

  • Anticipates feedback from a new OEM trial by mid-2026, with potential for commercial agreements.

  • Management expresses strong confidence in the strategic direction and expects continued operational improvements.

  • Focus remains on innovation, cost efficiency, and scaling the Sospira/Cespira joint venture.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more